BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 18030015)

  • 1. [Efficacy of S-1 combined with weekly Paclitaxel for gastric cancer with cancerous ascites].
    Hara A; Tsunemi S; Yamamoto M; Izumi N; Iwamoto S
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1815-8. PubMed ID: 18030015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical efficacy of biweekly paclitaxel and S-1 regimen for 14 gastric cancer patients with liver metastases].
    Ishigami S; Nakajo A; Uenosono Y; Okumura H; Matsumoto M; Arigami T; Uchikado Y; Setoyama T; Hokita S; Natsugoe S; Aikou T
    Gan To Kagaku Ryoho; 2007 Apr; 34(4):569-72. PubMed ID: 17431343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I/II trial of combination therapy with S-1 and weekly paclitaxel in patients with unresectable or recurrent gastric cancer.
    Inada S; Tomidokoro T; Fukunari H; Sato T; Hatano T; Nishimura A; Kawauchi Y; Nikkuni K; Shimizu T; Sato T; Yanagi M; Takahashi S; Yoshida H; Sugita M; Hayashi T
    Cancer Chemother Pharmacol; 2009 Jan; 63(2):267-73. PubMed ID: 18379784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A patient with advanced gastric cancer that response remarkably to combination chemotherapy of TS-1 and biweekly paclitaxel (TXL)].
    Tanaka A; Funai S; Ohtsuka H; Yoshifuji T; Hirai T; Shindo K; Shiozaki H; Kamei A
    Gan To Kagaku Ryoho; 2003 Sep; 30(9):1347-50. PubMed ID: 14518419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combination chemotherapy study of biweekly paclitaxel and S-1 administration in patients with advanced gastric cancer].
    Hokita S; Aikou T; Ishigami S; Miyazono F; Nakajo A; Uenosono Y; Hamanoue M; Aridome K; Natsugoe S
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():95-8. PubMed ID: 16897981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An unresectable advanced gastric cancer with Virchow's metastasis, carcinomatous ascites and rectal stenosis, effectively managed with combined chemotherapy of biweekly paclitaxel and TS-1].
    Shibata N; Eto TA; Hotokezaka M; Iwamura T; Chijiiwa K
    Gan To Kagaku Ryoho; 2005 Aug; 32(8):1159-62. PubMed ID: 16121920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of a combination of S-1 and paclitaxel in patients with unresectable or metastatic gastric cancer.
    Narahara H; Fujitani K; Takiuchi H; Sugimoto N; Inoue K; Uedo N; Tsukuma H; Tsujinaka T; Furukawa H; Taguchi T
    Oncology; 2008; 74(1-2):37-41. PubMed ID: 18544958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multi-center phase II study of S-1 plus paclitaxel as first-line therapy for patients with advanced or recurrent unresectable gastric cancer.
    Lee JJ; Kim SY; Chung HC; Lee KH; Song HS; Kang WK; Hong YS; Choi IS; Lee YY; Woo IS; Choi JH
    Cancer Chemother Pharmacol; 2009 May; 63(6):1083-90. PubMed ID: 18813927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Two advanced gastric cancer cases with peritoneal metastases successfully treated by s-1/paclitaxel combination therapy].
    Ina K; Furuta R; Kataoka T; Nishio T; Nagao S; Kayukawa S; Masaki A; Ando T; Goto H
    Gan To Kagaku Ryoho; 2009 Jun; 36(6):979-81. PubMed ID: 19542719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [S-1 combined with weekly paclitaxel in patients with advanced gastric cancer].
    Gotoh M; Kawabe S; Takiuchi H
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():91-4. PubMed ID: 16897980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter phase II study of biweekly paclitaxel and S-1 combination chemotherapy for unresectable or recurrent gastric cancer.
    Nakajo A; Hokita S; Ishigami S; Miyazono F; Etoh T; Hamanoue M; Maenohara S; Iwashita T; Komatsu H; Satoh K; Aridome K; Morita S; Natsugoe S; Takiuchi H; Nakano S; Maehara Y; Sakamoto J; Aikou T;
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):1103-9. PubMed ID: 18317763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of inoperable scirrhous gastric cancer that responded remarkably to a combination of TS-1+paclitaxel and showed complete loss of ascites].
    Takahashi Y; Hara A; Tokuhara T; Izumi N; Iwamoto S; Satake K
    Gan To Kagaku Ryoho; 2004 Jul; 31(7):1093-5. PubMed ID: 15272592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effective TS-1+paclitaxel administration for gastric cancer with malignant ascites--a case report].
    Sugihara S; Ikuta Y; Kobayashi H; Tsuruta Y; Yonemitsu K; Toyama E; Teshima K
    Gan To Kagaku Ryoho; 2005 Dec; 32(13):2109-11. PubMed ID: 16352938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of advanced gastric cancer with Schnitzler's metastases effectively treated by the combination of paclitaxel and S-1].
    Yamamoto M; Matsuyama A; Kameyama T; Okamoto M; Okazaki J; Utsunomiya T; Tsutsui S; Ishida T
    Gan To Kagaku Ryoho; 2008 May; 35(5):829-31. PubMed ID: 18487923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combination of S-1 and paclitaxel for advanced/recurrent gastric cancer patients with peritoneal metastasis, feasibility study (OGSG0401)].
    Kimura Y; Machida H; Fujitani K; Yamamoto M; Tominaga K; Yano H; Shimokawa T; Takiuchi H; Tsujinaka T; Furukawa H
    Gan To Kagaku Ryoho; 2010 Jan; 37(1):151-5. PubMed ID: 20087052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pilot study of neo-adjuvant chemotherapy involving intraperitoneal administration of paclitaxel and oral S-1 for patients with T3 gastric cancer].
    Tamura S; Miki H; Okada K; Yoshimura M; Uji K; Yoshida A; Suzuki R; Nakahira S; Egawa C; Nakata K; Okamura S; Sugimoto K; Takatsuka Y
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2024-6. PubMed ID: 19106511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical efficacy and safety of weekly paclitaxel therapy as second-line chemotherapy for patients with advanced and recurrent gastric cancer who were previously treated with TS-1 therapy].
    Hatori S; Kunisaki C; Ono H; Sato T; Otsuka Y; Yamada R; Ohshima T; Rino Y; Imada T
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1257-60. PubMed ID: 16969021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second-line chemotherapy with biweekly paclitaxel after failure of fluoropyrimidine-based treatment in patients with advanced or recurrent gastric cancer: a report from the gastrointestinal oncology group of the Tokyo cooperative oncology group, TCOG GC-0501 trial.
    Koizumi W; Akiya T; Sato A; Yamaguchi K; Sakuyama T; Nakayama N; Tanabe S; Higuchi K; Sasaki T; Sekikawa T;
    Jpn J Clin Oncol; 2009 Nov; 39(11):713-9. PubMed ID: 19812061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of paclitaxel-resistant cancerous ascites secondary to gastric carcinoma responding well to TS-1 therapy].
    Hara A; Tsunemi S; Yamamoto M; Izumi N; Iwamoto S
    Gan To Kagaku Ryoho; 2006 Dec; 33(13):2065-7. PubMed ID: 17197755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.
    Lee SJ; Cho SH; Yoon JY; Hwang JE; Bae WK; Shim HJ; Chung IJ
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):159-66. PubMed ID: 19479256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.